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The a-agglutinin responsible for mating type-specific agglutination of S. cerevisiae a-cells has been purified to homogenei- 
ty. The glycoprotein released from the cell surface under mild conditions has a relative molecular mass of 200 to 300 
kDa as determined by SDS-gel electrophoresis. The protein moiety corresponds to 68.2 kDa. With an oligonucleotide 
corresponding to the N-terminal amino acid sequence, the a-agglutinin gene has been cloned and sequenced. From the 
DNA sequence, a protein of 631 amino acids with 12 potential N-glycosylation sites is predicted. The carboxy terminal 
one-third of the protein is not required for agglutination activity. 
Agglutinin, a-; Glycoprotein; DNA sequence; (Saccharomyces cerevisiae) 
1. INTRODUCTION 
Haploid a- and a-cells of S. cerevisiae produce 
peptide pheromones, a- and a-factor, which, when 
experienced by the corresponding mating partner, 
cause a change of the cell surface and an increased 
agglutinability [l-4]. From a-cells, a glycoprotein 
of 22 kDa has been released from the cell surface 
which is present in 30-fold higher concentration 
after w-factor treatment [5]. This increase in 
amount corresponded well with the increase in 
biological activity [6]. From total extracts of CY- 
cells, another glycoprotein has been enriched 
which possesses cr-agglutinin activity [7]. 
In this paper, we describe the purification of a 
cell surface glycoprotein from a-cells, the amount 
of which increases 5-IO-fold after treating the cells 
with a-factor, again’ paralleling the increase in 
biological activity of corresponding cell extracts. 
This protein was released from intact cells with 
mild zymolyase treatment and had only to be 
purified about lo-fold to be homogeneous. The N- 
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terminal sequence of the protein was determined. 
With a corresponding oligonucleotide, the gene 
has been cloned and from the DNA sequence, the 
total amino acid sequence of cu-agglutinin is 
predicted. 
2. MATERIALS AND METHODS 
2. I. Strains and media 
S. cerevisiae X2180-IA (Mata) and X2180-IB (Mati) were 
grown in YPD medium (1% yeast extract, 2% bactopeptone, 
2% glucose) at 30°C. 
2.2. Pretreatment of a-cells with a factor 
2.5 1 of an overnight culture of X2180-1B (o-cells) with an 
ODS~S of 4.0, were centrifuged and resuspended in 5 1 a-cell 
medium. This preconditioned medium was obtained by re- 
moving X2180-1A cells of an overnight culture (ODsrs = 2.0) by 
centrifugation and filtering (nitrocellulose, pore size 0.45 cm). 
The cu-cells were growing for 90 min at 30°C in the u-medium. 
2.3. Preparation and purification of ru-agglutinin 
Pretreated o-cells were harvested, washed 3 times with 
100 mM Tris, pH 8.0, and 5 mM EDTA, resuspended in 60 ml 
of 20 mM potassium phosphate buffer, pH 7.0, resulting in 
130-140 OD units/ml. 6,~g zymolyase 100 T and 20,~g 
cycloheximide were added per ml and the incubation was car- 
ried out for 90 min at 30°C. After centrifugation, the superna- 
tant was run through an ion-exchange column (volume 12 ml; 
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Fig. 1. Fluorogram of “S-radiolabeled cell surface components 
of S. cerevisiae a+ells. 50 ml of ru-cefis (ODs7s = 1.0) were 
incubated in a defined sulfate-free medium [15] until the culture 
reached an OD of 1.7. Then, 20,&i of “SO$-/ml (spec. act., 
100 mCi/mmol) were added and the cells further incubated in 
the presence or absence of u-factor (10 units/ml) for 90 min at 
30°C. After harvesting the cells, their surface components were 
released and separated by SDS-gel electrophoresis as described 
in section 2.7. Crude extracts, lanes 1 and 2; active fractions 
after the first TSK column, lanes 3 and 4. 
Tris-Acryl M-DEAE, Pharmacia) and the activity (inhibition of 
a~utinat~on, see betow) eluted with a KC1 gradient 
(O-400 mM in 10 mM Tris-HC17.0). The active fractions were 
pooled, dialyzed against 2 mM Tris 7.0, and 5 mM EDTA and 
lyophilized. For HPLC gel filtration, the material was dissolved 
in 0.2-1.0 ml of 100 mM N&-acetate, pH 5.5 and separated 
on an LKB UltroPac TSK G 3000 SW column. The active frac- 
tions were pooled, dialyzed (as above) and concentrated in a 
Speed Vat. 
2.4. Agglutination assay (bioassay for a-agglutinin) 
Agglutination of pheromone-induced cells was measured by 
the procedure of Pierce and Ballou [I?]. 50~1 of Mata-cells 
(7.5 x lo6 cells) induced with a-factor were added to 125 ~1 of 
0.1 M sodium phosphate buffer, .pH 6.0, in flat-bottom 
microtiter plates (15 x 17 mm wells); subsequently 25 ~1 of ex- 
tract to be tested was added in increasing ~iutions (2: 1). After 
1 h of gentle shaking, 50 ~1 of u-factor-pretreated cY-cells (7.5 x 
lo6 cells) were added. After S-10 min of shaking, agglutination 
could easily be seen in non-inhibited controls. One assay unit is 
defined as the minimal amount of extract that clearly inhibited 
ag~utination under these conditions. Further details are given 
in a previous publication [5]. 
2.5. Digestion with EndoF 
250 mU endoglycosidase F (EndoF) from Boehringer Mann- 
heim were incubated with 500 fig protein in 50 mM sodium 
phosphate buffer, pH 6.1, containing 35 mM EDTA in a total 
volume of 100-200~1 overnight at 37°C. 
2.6. Cloning of the gene 
The yeast genomic library, kindly provided by Dr C. 
Sengstag, contained yeast DNA fragments of about 10 kb that 
had been obtained by partial Sau3A digest of DNA from S. 
cerevisiue wild type S288C. The fragments were ligated into a 
centromere vector PCS 19 [9]. DNA sequencing was performed 
according to Sanger et al. [lo], as detailed in [ll]. RNA analysis 
was carried out as described previously [l 11. 
2.7. Other procedures 
SDS and native gel electrophoreses were carried out accord- 
ing to Laemmli [12] and Barbaric et al. [13], respectively. Pro- 
tein was determined according to Bradford [14]. 
3. RESULTS AND DISCUSSION 
When a-factor-treated a-cells were incubated 
with 6 pg zymolyase 100 T/ml for 90 min, the 
Table 1 
Purification of cu-agglutinin 
Total protein Totat activity Spec. act. Pu~fication Yield 
olg) (units) (units/& (-fold) (%) 
Crude extract 5460 29120 5.3 100 
DEAE-Pool 2000 28000 14 2.6 96 
TSK 3000 730 25600 35 6.6 87 
TSK 2000 
after Endo F 130 9472 73 13.7 32 
5 ] cu-cells with O&78 of 3.1 after induction in u-medium were treated with 
zymolyase, which resulted in the crude extract; for details and further purification 
see section 2 
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Fig.2. Coomassie stained non-denaturing gradient gel 
separating polypeptides by size (according to 1131). Lanes 3 and 
4, cu-agglutinin-active fractions after first TSK column; lanes 1 
and 2, ff-agglutinin-active fractions after second TSK column 
(see also table 1). 
supernatant obtained after centrifugation strongly 
inhibited the agglutination of induced Q with CX- 
cells. Control a-cells released 5- to lo-fold less in- 
hibitory activity. Cells treated in this way with 
zymolyase remained intact and 100% viable (data 
not shown). With a-cells previously radiolabeled 
Table 2 
N-terminal amino acid sequences of the various polypeptides of 
cu-agglutinin obtained after Endo F treatment (fig.2, lane 1) 
Polypeptide 
(rel. molec. mass, kDa) 
N-terminal amino acid 
sequence 
72 ININD 
68 ININDITFSNLEITPLTANKQ 
61 ININD 
57 ININDITFSNLEIT 
54 ININ 
51 IN1 
with 3sSO$-, zymolyase released a number of cell 
surface components shown after SDS gel separa- 
tion in the fluorogram of fig.1 (lanes 1 and 2). 
Clearly, a large molecular mass (>200 kDa) was 
the only one, showing an increase of 5- to lo-fold, 
due to a-factor pretreatment. After two column 
chromatographic purification steps (table I), this 
large molecular mass material was enriched (fig. 1, 
lanes 3 and 4). When the gel filtration column was 
repeated after Endo F digest of the active fraction 
(see below), an even higher specific activity was ob- 
tained (table 1). 
Separation of the purified material (after the se- 
cond column) in a native-gradient gel resulted in 
the picture of fig.2, lane 2; in this case the material 
showed a relative molecular mass of 250 to 
400 kDa. The corresponding purified material of 
non-induced cells is hardly visible. After Endo F 
treatment, a fairly regular pattern of 5 to 6 bands 
was obtained (lane 1) with apparent relative 
molecular masses of 72, 68, 61, 57, 54, and 51 kDa 
(as determined by SDS-gel electrophoresis; data 
not shown). All these bands showed biological ac- 
tivity in the agglutination test. Since the activity 
obtained in each case correlated well with the in- 
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Fig.3. (a) Northern blot analysis. Total RNA of u-factor-treated 
(15 min) and control cells was isolated and hybridized (see 1111) 
with the BgflI-BumHI restriction fragment of clone 11 (see 
fig.3b, dashed lines). (b) Restriction endonuclease map of clone 
11 carrying the whole n-agglutinin gene (black box). B, BumHI; 
Bg, BgAI; E, EcoRI. Arrows, sequencing strategy; for 
explanation, see fig.4. 
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Fig.4. Nucleotide sequence and predicted amino acid sequence of the gene coding for rY-agglutinin. The N-terminal sequence was 
detected in the ~~~HI-~g~l fragment; for the rest of the gene, 12 overlapping subciones were sequenced, according to the downward 
arrow of fig.fb. Underlined is the N-terminal amino acid sequence corresponding to that of table 2. Triangles indicate potential N 
gIycosyiation sites. 
tensity of the Coomassie stain, the specific activity 
is estimated to be the same for each individual 
band. The protein characterized by Lipke et al. [7] 
also remained active after removal of car- 
bohydrates; the molecular masses of their proteins, 
however, differed considerably from those shown 
here. 
When the bands of fig.2 after blotting onto Im- 
mobilon foil were cut out and sequenced by Dr R. 
Deutzmann, Regensburg, the N-terminal amino 
acid sequences of all six bands were found to be 
identical (table 2). The reason for the difference in 
molecular masses of the bands is not known; pro- 
teolytic loss of carboxy termini of increasing size 
seems most likely, however (see below). 
The oligonucleotide 5 ’ GTG/TATGTCGTTG/ 
TATGTTGITAT was synthesized corresponding 
to the N-terminus ININDIT. It gave a strong signal 
on a Northern blot with mRNA from induced 1y- 
cells and a much weaker one with mRNA from 
non-induced cells (data not shown). 
When a yeast genomic library was screened wit1 
the oligonucleotide, 16 positive clones were ob, 
tained. A 1.5 kb fragment of clone 11 with a tota, 
insert of 9.5 kb also reacted with mRNA of a- 
factor-induced cells considerably stronger than 
with that of control cells (fig.3). That this clone 
was a good candidate for the correct gene or part 
of it, was furthermore strengthened by the fact 
that mRNA of a-cells did not give a signal (fig.3a, 
lane 1) and that the signal of a-cells corresponded 
to a mRNA size of approximately 2.3 kb. 
Subcloning clone 11 and sequencing according 
to Sanger et al. [lo] resulted in the sequence given 
in fig.4. An open reading frame of 1950 bp cor- 
responds to a protein of 650 amino acids contain- 
ing the N-terminal 21 amino acids of table 2. Thus, 
the leader peptide is 19 amino acids long. The 
relative molecular mass of 68239 kDa of the 
mature protein agrees well with the 72 kDa deter- 
mined for the largest polypeptide after Endo F 
treatment. Since 12 N-acetyl glucosamine residues 
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(= 2450 kDa) are likely to be attached to the 
polypeptide, according to 12 potential N- 
glycosylation sites in the sequence (fig.4), the pro- 
tein moiety of the band most likely corresponds to 
69500. The additional five bands on the gel (fig.2), 
therefore, seem to be proteolytic carboxy terminal 
deletions of increasing length. Since even the 
smallest polypeptide (5 1 kDa) is biologically active 
in preventing agglutination, the carboxy terminal 
one-third of the molecule seems not to be involved 
in the agglutination reaction. 
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